Circ_0004851 regulates the molecular mechanism of miR-296-3p/FGF11 in the influence of high iodine on PTC

Jinɡjinɡ Li, Zixuan Ru, Xu Yang, Jingxue Sun, Yanmeizhi Wu, Xiaoyao Yang, Bo-Yu Hou, Bing Xue, Chao Ding, Hong QiaoJournal of Translational Medicine 2024 · DOI

Abstract

The prevalence of papillary thyroid cancer (PTC) has been rising in recent years. Despite its relatively low mortality, PTC frequently metastasizes to lymph nodes and often recurs, posing significant health and economic burdens. The role of iodine in the pathogenesis and advancement of thyroid cancer remains poorly understood. Circular RNAs (circRNAs) are recognized to function as competing endogenous RNAs (ceRNAs) that modulate gene expression and play a role in various cancer stages. Consequently, this research aimed to elucidate the mechanism by which circRNA influences the impact of iodine on PTC. Our research indicates that high iodine levels can exacerbate the malignancy of PTC via the circ_0004851/miR-296-3p/FGF11 axis. These insights into iodine's biological role in PTC and the association of circRNA with the disease could pave the way for novel biomarkers and potentially effective therapeutic strategies to mitigate PTC progression.

Introduction

Papillary Thyroid Cancer (PTC) is the most common endocrine malignancy globally. While iodine is essential for thyroid health, its role in cancer progression is complex and controversial. Epidemiological data suggests that both iodine deficiency and excess are linked to thyroid pathology, but the exact molecular mechanism by which high iodine levels influence existing PTC has remained a "black box." This study reveals that high iodine levels exacerbate the malignancy of PTC by activating a specific molecular pathway: the circ_0004851/miR-296-3p/FGF11 axis.

Methodology

The researchers employed a multi-disciplinary approach combining clinical data, high-throughput sequencing, and functional molecular biology:

  • Clinical Analysis: Correlation of serum iodine levels with tumor characteristics (size, metastasis) in a cohort of 1,431 patients.
  • Transcriptomics: RNA-Seq on PTC tissues from patients with high (IE) vs. normal (IN) iodine levels to identify differentially expressed RNAs.
  • Functional Assays: Testing proliferation, migration, and invasion in PTC cell lines (BCPAP, TPC-1) under varying iodine concentrations.
  • Interaction Testing: Dual-luciferase reporter assays to prove physical binding between circ_0004851, miR-296-3p, and the target gene FGF11.

The Biphasic Effect of Iodine on PTC Malignancy

The study confirms that iodine's impact on PTC cells follows a biphasic pattern. Moderate-high levels ($10^{-6}$ mol/L) significantly promote malignancy, increasing cell viability, migration, and invasion while reducing apoptosis. Conversely, extremely high levels ($10^{-3}$ mol/L) can actually inhibit growth, highlighting the importance of precise iodine regulation.

Figure 5: High iodine ($10^{-6}$ M) promotes PTC cell viability, migration, and invasion while inhibiting apoptosis, whereas extremely high iodine ($10^{-3}$ M) has inhibitory effects.

Molecular Mechanism: The circ_0004851/miR-296-3p/FGF11 Axis

The paper identifies circ_0004851 as a critical regulator. In high-iodine environments, this circRNA is upregulated and acts as a "molecular sponge" for miR-296-3p. Normally, miR-296-3p acts as a brake on FGF11 (Fibroblast Growth Factor 11). When the circRNA sponges the miRNA, the brake is released, leading to an overabundance of FGF11, which drives tumor proliferation and inhibits programmed cell death.

Figure 6: Transcriptomic analysis and validation of the circ_0004851/miR-296-3p/FGF11 axis in high-iodine PTC tissues and cell lines.

Key Results and Clinical Correlation

  • Clinical Impact: High serum iodine was significantly correlated with bilateral lesions, larger tumor size ($>1$ cm), multiple tumor foci, and lymph node metastasis ($p < 0.05$).
  • In Vivo Validation: In mouse models, high iodine intake led to significantly larger tumor volumes and weights compared to control groups.
  • Rescue Experiments: Silencing circ_0004851 or overexpressing miR-296-3p effectively reversed the malignant phenotypes induced by high iodine, restoring apoptotic pathways.

Conclusion

This research provides a novel molecular explanation for how iodine excess promotes PTC progression. While further study is needed on the temporal dynamics of iodine levels and other thyroid cancer subtypes, the identification of the circ_0004851/miR-296-3p/FGF11 axis offers potential new biomarkers and therapeutic targets for managing aggressive PTC.

Summary updated

Abstract

The prevalence of papillary thyroid cancer (PTC) has been rising in recent years. Despite its relatively low mortality, PTC frequently metastasizes to lymph nodes and often recurs, posing significant health and economic burdens. The role of iodine in the pathogenesis and advancement of thyroid cancer remains poorly understood. Circular RNAs (circRNAs) are recognized to function as competing endogenous RNAs (ceRNAs) that modulate gene expression and play a role in various cancer stages. Consequently, this research aimed to elucidate the mechanism by which circRNA influences the impact of iodine on PTC. Our research indicates that high iodine levels can exacerbate the malignancy of PTC via the circ_0004851/miR-296-3p/FGF11 axis. These insights into iodine's biological role in PTC and the association of circRNA with the disease could pave the way for novel biomarkers and potentially effective therapeutic strategies to mitigate PTC progression.
BibTeX
@article{li2024circ,
  author = {Jinɡjinɡ Li and Zixuan Ru and Xu Yang and Jingxue Sun and Yanmeizhi Wu and Xiaoyao Yang and Bo-Yu Hou and Bing Xue and Chao Ding and Hong Qiao},
  title = {{Circ\_0004851 regulates the molecular mechanism of miR-296-3p/FGF11 in the influence of high iodine on PTC}},
  journal = {Journal of Translational Medicine},
  year = {2024},
  doi = {10.1186/s12967-024-05405-2},
}
Figure